# MODAFIMS: A Trial to Evaluate Predictors of Response to MODAFinil in Patients With Multiple Sclerosis

> **NCT06592352** · PHASE2 · RECRUITING · sponsor: **Clinical Academic Center (2CA-Braga)** · enrollment: 64 (estimated)

## Conditions studied

- Multiple Sclerosis
- Cognitive Impairment

## Interventions

- **DRUG:** Modafinil Generis 100 mg

## Key facts

- **NCT ID:** NCT06592352
- **Lead sponsor:** Clinical Academic Center (2CA-Braga)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-27
- **Primary completion:** 2026-06
- **Final completion:** 2026-09
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06592352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06592352, "MODAFIMS: A Trial to Evaluate Predictors of Response to MODAFinil in Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06592352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*